Clinical Practice Guideline: Age-Related Hearing Loss Executive Summary

被引：3

作者：

Tsai Do, Betty S. ^{[1
]}

Bush, Matthew L. ^{[2
]}

Weinreich, Heather M. ^{[3
]}

Schwartz, Seth R. ^{[4
]}

Anne, Samantha ^{[5
]}

Adunka, Oliver F. ^{[6
]}

Bender, Kaye ^{[7
]}

Bold, Kristen M. ^{[8
]}

Brenner, Michael J. ^{[9
]}

Hashmi, Ardeshir Z. ^{[5
]}

Kim, Ana H. ^{[10
]}

Keenan, Teresa A. ^{[11
]}

Moore, Denee J. ^{[12
]}

Nieman, Carrie L. ^{[13
]}

Palmer, Catherine V. ^{[14
]}

Ross, Erin J. ^{[5
]}

Steenerson, Kristen K. ^{[15
]}

Zhan, Kevin Y. ^{[16
]}

Reyes, Joe ^{[17
]}

Dhepyasuwan, Nui ^{[17
]}

机构：

[1] Permanente Med Grp Inc, Walnut Creek, CA USA

[2] Univ Kentucky, Med Ctr, Lexington, KY USA

[3] Univ Illinois, Chicago, IL USA

[4] Virginia Mason Med Ctr, Seattle, WA USA

[5] Cleveland Clin, Cleveland, OH USA

[6] Ohio State Univ, Columbus, OH USA

[7] Mississippi Publ Hlth Assoc, Jackson, MS USA

[8] UT Southwestern Med Ctr, Dallas, TX USA

[9] Univ Michigan, Med Sch, Ann Arbor, MI USA

[10] Columbia Univ, Med Ctr, New York, NY USA

[11] AARP, Washington, DC USA

[12] VCU, Sch Med, Richmond, VA USA

[13] Johns Hopkins Univ, Sch Med, Baltimore, MD USA

[14] Univ Pittsburgh, Pittsburgh, PA USA

[15] Stanford Univ, Palo Alto, CA USA

[16] Northwestern Med, Chicago, IL USA

[17] Amer Acad Otolaryngol Head & Neck Surg Fdn, Alexandria, VA USA

来源：

OTOLARYNGOLOGY-HEAD AND NECK SURGERY | 2024年 / 170卷 / 05期

关键词：

age-related hearing loss; amplification; cochlear implantation; presbycusis; sensorineural hearing loss; TRANSCRANIAL MAGNETIC STIMULATION; NUTRITION EXAMINATION SURVEY; QUALITY-OF-LIFE; CHRONIC TINNITUS; OLDER-ADULTS; PHYSICAL-ACTIVITY; ELECTRICAL-STIMULATION; AUDITORY-CORTEX; NATIONAL-HEALTH; NOISE EXPOSURE;

D O I：

10.1002/ohn.749

中图分类号：

R76 [耳鼻咽喉科学];

学科分类号：

100213 ;

摘要：

ObjectiveAge-related hearing loss (ARHL) is a prevalent but often underdiagnosed and undertreated condition among individuals aged 50 and above. It is associated with various sociodemographic factors and health risks including dementia, depression, cardiovascular disease, and falls. While the causes of ARHL and its downstream effects are well defined, there is a lack of priority placed by clinicians as well as guidance regarding the identification, education, and management of this condition.PurposeThe purpose of this clinical practice guideline is to identify quality improvement opportunities and provide clinicians trustworthy, evidence-based recommendations regarding the identification and management of ARHL. These opportunities are communicated through clear actionable statements with an explanation of the support in the literature, the evaluation of the quality of the evidence, and recommendations on implementation. The target patients for the guideline are any individuals aged 50 years and older. The target audience is all clinicians in all care settings. This guideline is intended to focus on evidence-based quality improvement opportunities judged most important by the Guideline Development Group (GDG). It is not intended to be a comprehensive, general guide regarding the management of ARHL. The statements in this guideline are not intended to limit or restrict care provided by clinicians based on their experience and assessment of individual patients.Action StatementsThe GDG made strong recommendations for the following key action statements (KASs): (KAS 4) If screening suggests hearing loss, clinicians should obtain or refer to a clinician who can obtain an audiogram. (KAS 8) Clinicians should offer, or refer to a clinician who can offer, appropriately fit amplification to patients with ARHL. (KAS 9) Clinicians should refer patients for an evaluation of cochlear implantation candidacy when patients have appropriately fit amplification and persistent hearing difficulty with poor speech understanding. The GDG made recommendations for the following KASs: (KAS 1) Clinicians should screen patients aged 50 years and older for hearing loss at the time of a health care encounter. (KAS 2) If screening suggests hearing loss, clinicians should examine the ear canal and tympanic membrane with otoscopy or refer to a clinician who can examine the ears for cerumen impaction, infection, or other abnormalities. (KAS 3) If screening suggests hearing loss, clinicians should identify sociodemographic factors and patient preferences that influence access to and utilization of hearing health care. (KAS 5) Clinicians should evaluate and treat or refer to a clinician who can evaluate and treat patients with significant asymmetric hearing loss, conductive or mixed hearing loss, or poor word recognition on diagnostic testing. (KAS 6) Clinicians should educate and counsel patients with hearing loss and their family/care partner(s) about the impact of hearing loss on their communication, safety, function, cognition, and quality of life. (KAS 7) Clinicians should counsel patients with hearing loss on communication strategies and assistive listening devices. (KAS 10) For patients with hearing loss, clinicians should assess if communication goals have been met and if there has been improvement in hearing-related quality of life at a subsequent health care encounter or within 1 year. The GDG offered the following KAS as an option: (KAS 11) Clinicians should assess hearing at least every 3 years in patients with known hearing loss or with reported concern for changes in hearing.

引用

页码：1209 / 1227

页数：19

共 179 条

[1] Linking the Tinnitus Questionnaire and the subjective Clinical Global Impression: Which differences are clinically important? [J].